More pharmas expected to sign drug pricing deals with Trump on Friday - report
Source: SeekingAlpha
2025-12-17 13:09:06 ET
More on Amgen, Bristol Myers Squibb
- Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call Transcript
- Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call - Slideshow
- Amgen: Improving Balance Sheet Is Bringing The Stock Close To Being A "Buy"
- Bristol Myers Squibb upgraded at Guggenheim on 2026 pipeline catalysts
- Amgen granted FDA nod for Uplizna in myasthenia gravis
Read the full article on Seeking Alpha
For further details see:
More pharmas expected to sign drug pricing deals with Trump on Friday - report
Novartis AG
NASDAQ: NVS
NVS Trading
0.14% G/L:
$143.57 Last:
367,989 Volume:
$142.47 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
